1. Home
  2. PRE vs IMRX Comparison

PRE vs IMRX Comparison

Compare PRE & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prenetics Global Limited

PRE

Prenetics Global Limited

HOLD

Current Price

$20.54

Market Cap

369.7M

Sector

Industrials

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$5.01

Market Cap

322.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRE
IMRX
Founded
2014
2008
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
369.7M
322.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PRE
IMRX
Price
$20.54
$5.01
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$32.00
$17.20
AVG Volume (30 Days)
282.8K
601.3K
Earning Date
01-01-0001
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.75
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$105.52
N/A
Revenue Next Year
$58.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$1.10
52 Week High
$22.86
$10.08

Technical Indicators

Market Signals
Indicator
PRE
IMRX
Relative Strength Index (RSI) 60.03 45.94
Support Level $12.35 $4.83
Resistance Level $20.89 $5.36
Average True Range (ATR) 1.67 0.29
MACD 0.45 0.04
Stochastic Oscillator 75.65 19.64

Price Performance

Historical Comparison
PRE
IMRX

About PRE Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: